Breaking News Instant updates and real-time market news.

CLVS

Clovis

$35.77

-1.51 (-4.05%)

, AZN

AstraZeneca

$32.26

-0.34 (-1.04%)

09:06
10/07/16
10/07
09:06
10/07/16
09:06

Clovis rucaparib comparison to Lynparza 'not looking so hot,' says Feuerstein

After Clovis Oncology (CLVS) announced the oral presentation of the primary efficacy and safety data from its NDA dataset for rucaparib, which is currently under priority review with FDA for the monotherapy treatment of advanced ovarian cancer in select patients, Adam Feuerstein, biotech reporter for TheStreet.com, commented on Twitter that the comparison of Clovis' data to AstraZeneca's (AZN) Lynparza are "not looking so hot." Shares of Clovis are now down over 26% in pre-market trading. Reference Link

CLVS

Clovis

$35.77

-1.51 (-4.05%)

AZN

AstraZeneca

$32.26

-0.34 (-1.04%)

  • 07

    Oct

  • 06

    Nov

  • 16

    Nov

  • 23

    Feb

CLVS Clovis
$35.77

-1.51 (-4.05%)

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
JANY
09/21/16
DOWNGRADE
JANY
Neutral
Clovis downgraded to Neutral from Buy at Janney Capital
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).
10/04/16
PIPR
10/04/16
NO CHANGE
Target $42
PIPR
Neutral
Clovis price target raised to $42 from $14 at Piper Jaffray
Piper Jaffray analyst Steven Breazzano raised his price target for Clovis Oncology (CLVS) to $42 after taking a "comprehensive look" at the PARP inhibitor landscape in ovarian cancer and beyond. The company's PARP inhibitor rucaparib has demonstrated an active profile in ovarian cancer and all signs point to an approval in the 3L+ setting early next year, Breazzano tells investors in a research note. The analyst, however, believes the ultimate key is success in the earlier maintenance setting, and he thinks the race may still be Tesaro's (TSRO) niraparib's to lose. Breazzano keeps a Neutral rating on Clovis.
AZN AstraZeneca
$32.26

-0.34 (-1.04%)

09/12/16
09/12/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pandora (P) upgraded to Buy from Neutral at SunTrust with analyst Robert Peck saying he thinks that a new interactive offering by the company could raise its contribution profit by 4%-9% and that the Street's 2017 estimates for the company "seem conservative." The analyst added that he thinks it's "very possible" that Pandora will be acquired. 2. AstraZeneca (AZN) upgraded to Buy from Hold at Jefferies with analyst Jeffrey Holford saying the company's MYSTIC oncology study could drive 39% share upside if successful. 3. Apache (APA) and upgraded to Overweight from Neutral at Atlantic Equities and to Peer Perform from Underperform at Wolfe Research. 4. Philip Morris (PM) upgraded to Conviction Buy from Neutral at Goldman with analyst Judy Hong saying she is increasingly bullish on the prospects of Next Generation Products and expects them to contribute 5%-6% of earnings by 2020. 5. Wal-Mart (WMT) upgraded to Outperform from Market Perform at Cowen with analysts led by Oliver Chen saying price investments, integration of physical and digital, and the Jet acquisitions position the company to regain its dominance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/16
EXAN
09/13/16
DOWNGRADE
EXAN
Neutral
AstraZeneca downgraded to Neutral from Outperform at Exane BNP Paribas
09/23/16
PIPR
09/23/16
INITIATION
PIPR
Overweight
AstraZeneca initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started AstraZeneca with an Overweight rating and GBP 60 price target.
09/23/16
09/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Brian Nowak initiated Activision Blizzard (ATVI) and Electronic Arts (EA), both with Overweight ratings. The analyst is bullish on the digital gaming shift away from "units sold" to a business model based on users, engagement, and digital monetization. He sees digital in-game offerings resulting in recurring and growth user bases, increased per-game engagement, and further monetization opportunities. 2. AstraZeneca (AZN) and GlaxoSmithKline (GSK) both initiated with Overweight ratings by Piper Jaffray analyst Richard Purkiss. 3. Achillion (ACHN) initiated with an Outperform by Wedbush analyst Heather Behanna, who set a $13 price target on the shares. 4. Sysco (SYY) initiated with an Underweight at Barclays and $48 price target by analyst Karen Short. 5. Five Below (FIVE), Dollar Tree (DLTR) and Dollar General (DG) all initiated with Equal Weight ratings by Barclays analyst Karen Short. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$15.05

-0.13 (-0.86%)

, UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

16:45
12/02/16
12/02
16:45
12/02/16
16:45
Hot Stocks
Tenet, UnitedHealthcare renew national relationship for four years »

Tenet Healthcare (THC)…

THC

Tenet

$15.05

-0.13 (-0.86%)

UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$12.24

-0.19 (-1.53%)

16:43
12/02/16
12/02
16:43
12/02/16
16:43
Periodicals
Ford CEO willing to work with Trump to keep jobs in U.S., Bloomberg says »

Ford CEO Mark Fields said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

BAC

Bank of America

$21.23

-0.27 (-1.26%)

16:40
12/02/16
12/02
16:40
12/02/16
16:40
Options
Long-dated Bank of America calls rolled out to 2019 15 point spread »

Long-dated Bank of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Jan

DPZ

Domino's Pizza

$168.00

-0.7 (-0.41%)

16:39
12/02/16
12/02
16:39
12/02/16
16:39
Syndicate
Breaking Syndicate news story on Domino's Pizza »

Domino's Pizza files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Jan

ALKS

Alkermes

$56.25

1.36 (2.48%)

16:39
12/02/16
12/02
16:39
12/02/16
16:39
Hot Stocks
Alkermes COO and Chief Risk Officer Gordon Pugh to resign »

On November 29, Mr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

, VRX

Valeant

$15.45

0.14 (0.91%)

16:34
12/02/16
12/02
16:34
12/02/16
16:34
General news
On The Fly: Stocks end week mixed as Trump rally loses steam, oil surges »

The major averages ended…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

VRX

Valeant

$15.45

0.14 (0.91%)

GM

General Motors

$35.41

-1.02 (-2.80%)

F

Ford

$12.24

-0.19 (-1.53%)

FCAU

Fiat Chrysler

$7.63

-0.11 (-1.42%)

AAPL

Apple

$109.86

0.37 (0.34%)

AMZN

Amazon.com

$740.34

-3.31 (-0.45%)

BX

Blackstone

$25.86

-0.29 (-1.11%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

TIME

Time Inc.

$16.00

-0.2 (-1.23%)

LNEGY

Linde

$16.77

0.09 (0.54%)

PX

Praxair

$119.58

-0.15 (-0.13%)

PH

Parker-Hannifin

$141.90

-1.57 (-1.09%)

CLC

Clarcor

$82.46

-0.12 (-0.15%)

TIF

Tiffany

$81.30

-1.21 (-1.47%)

THO

Thor Industries

$101.48

-1.5 (-1.46%)

SPLK

Splunk

$53.68

0.35 (0.66%)

ASNA

Ascena Retail

$7.01

1.18 (20.24%)

FIVE

Five Below

$43.82

3.94 (9.88%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

AEO

American Eagle

$16.17

-0.57 (-3.41%)

ADSK

Autodesk

$70.57

1.35 (1.95%)

DG

Dollar General

$74.56

1.08 (1.47%)

EXPR

Express

$10.79

0.15 (1.41%)

GES

Guess

$12.91

-0.85 (-6.18%)

WDAY

Workday

$71.40

-10.2 (-12.50%)

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

AMBA

Ambarella

$54.47

-6.92 (-11.27%)

SWHC

Smith & Wesson

$21.10

-2.88 (-12.01%)

UNH

UnitedHealth

$160.73

-0.21 (-0.13%)

CAT

Caterpillar

$95.14

-1.1 (-1.14%)

JPM

JPMorgan

$81.60

-0.19 (-0.23%)

BLK

BlackRock

$371.36

-5.84 (-1.55%)

DIS

Disney

$98.50

-0.44 (-0.44%)

WMT

Wal-Mart

$70.88

0.21 (0.30%)

IBM

IBM

$160.02

0.2 (0.13%)

CTSH

Cognizant

$54.02

-0.06 (-0.11%)

T

AT&T

$38.61

-0.27 (-0.69%)

TWX

Time Warner

$93.80

-0.34 (-0.36%)

GPRO

GoPro

$9.70

-0.12 (-1.22%)

NSANY

Nissan

$18.68

-0.05 (-0.27%)

TM

Toyota

$116.83

-0.94 (-0.80%)

VLKAY

Volkswagen

$27.18

-0.05 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 05

    Dec

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

  • 05

    Jan

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 16

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Jul

  • 12

    Oct

CASI

CASI Pharmaceuticals

$1.35

0.1009 (8.07%)

16:33
12/02/16
12/02
16:33
12/02/16
16:33
Syndicate
Breaking Syndicate news story on CASI Pharmaceuticals »

CASI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$18.40

0.6 (3.37%)

16:31
12/02/16
12/02
16:31
12/02/16
16:31
Syndicate
Breaking Syndicate news story on Hi-Crush Partners »

Hi-Crush Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$18.40

0.6 (3.37%)

16:31
12/02/16
12/02
16:31
12/02/16
16:31
Syndicate
Breaking Syndicate news story on Hi-Crush Partners »

Hi-Crush Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/02/16
12/02
16:30
12/02/16
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

, WDAY

Workday

$71.40

-10.2 (-12.50%)

16:28
12/02/16
12/02
16:28
12/02/16
16:28
General news
On The Fly: Top stock stories for Friday »

Stocks began the day with…

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

WDAY

Workday

$71.40

-10.2 (-12.50%)

P

Pandora

$13.33

1.85 (16.12%)

SIRI

Sirius XM

$4.30

-0.255 (-5.60%)

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

BX

Blackstone

$25.86

-0.29 (-1.11%)

GM

General Motors

$35.41

-1.02 (-2.80%)

JPM

JPMorgan

$81.60

-0.19 (-0.23%)

BLK

BlackRock

$371.36

-5.84 (-1.55%)

DIS

Disney

$98.50

-0.44 (-0.44%)

WMT

Wal-Mart

$70.88

0.21 (0.30%)

IBM

IBM

$160.02

0.2 (0.13%)

INFO

IHS Markit

$34.88

-0.23 (-0.66%)

ASNA

Ascena Retail

$7.01

1.18 (20.24%)

FIVE

Five Below

$43.82

3.94 (9.88%)

AMBA

Ambarella

$54.47

-6.92 (-11.27%)

SWHC

Smith & Wesson

$21.10

-2.88 (-12.01%)

ATI

Allegheny Technologies

$16.93

-0.83 (-4.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

FLDM

Fluidigm

$6.68

0.2 (3.09%)

16:25
12/02/16
12/02
16:25
12/02/16
16:25
Hot Stocks
Fluidigm CEO acquires 55,000 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSON

Hudson Global

$1.47

0.01 (0.68%)

16:25
12/02/16
12/02
16:25
12/02/16
16:25
Hot Stocks
Sagard exits stake in Hudson Global »

This was reported in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLA

Delta Apparel

$21.39

0.24 (1.13%)

16:22
12/02/16
12/02
16:22
12/02/16
16:22
Hot Stocks
Delta Apparel chief accounting officer DuVall resigns »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$14.03

-0.04 (-0.28%)

16:20
12/02/16
12/02
16:20
12/02/16
16:20
Options
Closing CBOE SPX and VIX Index summary for December 2nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EW

Edwards Lifesciences

$83.35

1.88 (2.31%)

16:19
12/02/16
12/02
16:19
12/02/16
16:19
Hot Stocks
Edward Lifesciences' Szyman acquires 12,870 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$NYE

NYSE Market Internals

16:16
12/02/16
12/02
16:16
12/02/16
16:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.